Crista Biologics delivers an innovative therapeutic platform to patients with refractory disease associated with mitochondrial abnormalities such as advanced heart failure, mitochondrial disease, sarcopenia/aging, and neurodegeneration disease. Mitochondria-rich extracellular vesicles (M-EVs) generated from iCMs contain healthy mitochondria and bioactive proteomes. M-EV-mediated mitochondrial transplantation therapy will restore the energy metabolism of the failing heart. We anticipate that this therapy will enhance the energetics of all cells in the human body.
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
